Artículo

Circulating MicroRNA-122 signature in nonalcoholic fatty liver disease and cardiovascular disease: A new endocrine system in metabolic syndrome

Pirola, Carlos JoséIcon ; Fernández Gianotti, TomásIcon ; Castaño, Gustavo Osvaldo; Sookoian, Silvia CristinaIcon
Fecha de publicación: 06/2013
Editorial: John Wiley & Sons Inc
Revista: Hepatology (Baltimore, Md.)
ISSN: 0270-9139
Idioma: Inglés
Tipo de recurso: Artículo publicado
Clasificación temática:

Resumen

To the Editor: We read with great interest the article by Bala et al. about the role of circulating microRNAs (miRNAs) as markers of alcohol‐ and acetaminophen‐induced liver damage in a mouse model; the investigators concluded that circulating miR‐122 and miR‐155 may serve as biomarkers of liver injury and inflammation, respectively.
Palabras clave: MIRNA 122 , ENDOCRINE , NAFLD , CARDIOVASCULAR DISEASE , PLASMA
 
Archivos asociados
Thumbnail
 
Tamaño: 366.1Kb
Formato: PDF
.
Licencia
info:eu-repo/semantics/openAccess Excepto donde se diga explícitamente, este item se publica bajo la siguiente descripción: Creative Commons Attribution-NonCommercial-ShareAlike 2.5 Unported (CC BY-NC-SA 2.5)
Identificadores
URI: http://hdl.handle.net/11336/84829
DOI: https://doi.org/10.1002/hep.26116
URL: https://aasldpubs.onlinelibrary.wiley.com/doi/full/10.1002/hep.26116
URL: https://pubmed.ncbi.nlm.nih.gov/23111985/
Colecciones
Articulos(IDIM)
Articulos de INST.DE INVEST.MEDICAS
Citación
Pirola, Carlos José; Fernández Gianotti, Tomás; Castaño, Gustavo Osvaldo; Sookoian, Silvia Cristina; Circulating MicroRNA-122 signature in nonalcoholic fatty liver disease and cardiovascular disease: A new endocrine system in metabolic syndrome; John Wiley & Sons Inc; Hepatology (Baltimore, Md.); 57; 6; 6-2013; 2545-2547
Compartir
Altmétricas